Annual Non Current Assets
$1.06 B
-$118.47 M-10.02%
December 31, 2023
Summary
- As of February 7, 2025, PCRX annual long term assets is $1.06 billion, with the most recent change of -$118.47 million (-10.02%) on December 31, 2023.
- During the last 3 years, PCRX annual non current assets has risen by +$441.50 million (+70.88%).
- PCRX annual non current assets is now -11.98% below its all-time high of $1.21 billion, reached on December 31, 2021.
Performance
PCRX Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$831.72 M
-$182.88 M-18.03%
September 30, 2024
Summary
- As of February 7, 2025, PCRX quarterly long term assets is $831.72 million, with the most recent change of -$182.88 million (-18.03%) on September 30, 2024.
- Over the past year, PCRX quarterly non current assets has dropped by -$255.49 million (-23.50%).
- PCRX quarterly non current assets is now -32.07% below its all-time high of $1.22 billion, reached on March 31, 2022.
Performance
PCRX Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
PCRX Non Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -10.0% | -23.5% |
| 3 y3 years | +70.9% | -32.1% |
| 5 y5 years | +403.5% | -32.1% |
PCRX Non Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -12.0% | at low | -32.1% | at low |
| 5 y | 5-year | -12.0% | +151.9% | -32.1% | +113.4% |
| alltime | all time | -12.0% | +3351.2% | -32.1% | +2596.8% |
Pacira BioSciences Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $831.72 M(-18.0%) |
| Jun 2024 | - | $1.01 B(-2.5%) |
| Mar 2024 | - | $1.04 B(-2.3%) |
| Dec 2023 | $509.99 M(+2.3%) | $1.06 B(-2.1%) |
| Sep 2023 | - | $1.09 B(-2.3%) |
| Jun 2023 | - | $1.11 B(-3.0%) |
| Mar 2023 | - | $1.15 B(-3.0%) |
| Dec 2022 | $498.33 M(-42.5%) | $1.18 B(-1.5%) |
| Sep 2022 | - | $1.20 B(-0.6%) |
| Jun 2022 | - | $1.21 B(-1.4%) |
| Mar 2022 | - | $1.22 B(+1.3%) |
| Dec 2021 | $866.05 M(+32.9%) | $1.21 B(+126.6%) |
| Sep 2021 | - | $533.65 M(+0.1%) |
| Jun 2021 | - | $533.25 M(-6.0%) |
| Mar 2021 | - | $567.30 M(-8.9%) |
| Dec 2020 | $651.62 M(+59.5%) | $622.89 M(+10.9%) |
| Sep 2020 | - | $561.75 M(+36.9%) |
| Jun 2020 | - | $410.29 M(+5.3%) |
| Mar 2020 | - | $389.79 M(-7.7%) |
| Dec 2019 | $408.56 M(-14.5%) | $422.51 M(-1.4%) |
| Sep 2019 | - | $428.64 M(+9.0%) |
| Jun 2019 | - | $393.23 M(+86.8%) |
| Mar 2019 | - | $210.48 M(-0.4%) |
| Dec 2018 | $477.97 M(+22.2%) | $211.38 M(+13.0%) |
| Sep 2018 | - | $187.00 M(-0.3%) |
| Jun 2018 | - | $187.63 M(-7.7%) |
| Mar 2018 | - | $203.30 M(-14.3%) |
| Dec 2017 | $391.11 M | $237.26 M(-1.2%) |
| Sep 2017 | - | $240.25 M(+55.2%) |
| Jun 2017 | - | $154.75 M(+1.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2017 | - | $152.00 M(+2.4%) |
| Dec 2016 | $243.09 M(-3.8%) | $148.38 M(+1.8%) |
| Sep 2016 | - | $145.71 M(+2.1%) |
| Jun 2016 | - | $142.71 M(+0.1%) |
| Mar 2016 | - | $142.58 M(+5.5%) |
| Dec 2015 | $252.58 M(+17.9%) | $135.15 M(-0.5%) |
| Sep 2015 | - | $135.89 M(+8.4%) |
| Jun 2015 | - | $125.37 M(+8.8%) |
| Mar 2015 | - | $115.28 M(+3.1%) |
| Dec 2014 | $214.26 M(+100.7%) | $111.81 M(+5.3%) |
| Sep 2014 | - | $106.15 M(+27.6%) |
| Jun 2014 | - | $83.17 M(+27.5%) |
| Mar 2014 | - | $65.22 M(+3.4%) |
| Dec 2013 | $106.75 M(+75.2%) | $63.07 M(+3.9%) |
| Sep 2013 | - | $60.71 M(+6.6%) |
| Jun 2013 | - | $56.94 M(+1.2%) |
| Mar 2013 | - | $56.25 M(+10.0%) |
| Dec 2012 | $60.92 M(-26.3%) | $51.13 M(+7.2%) |
| Sep 2012 | - | $47.70 M(+11.5%) |
| Jun 2012 | - | $42.78 M(+33.7%) |
| Mar 2012 | - | $32.00 M(+3.8%) |
| Dec 2011 | $82.65 M(+166.1%) | $30.84 M(-9.8%) |
| Sep 2011 | - | $34.21 M(+2.2%) |
| Jun 2011 | - | $33.49 M(-1.0%) |
| Mar 2011 | - | $33.84 M(-4.7%) |
| Dec 2010 | $31.05 M(+147.5%) | $35.51 M(+9.7%) |
| Sep 2010 | - | $32.37 M(+3.4%) |
| Jun 2010 | - | $31.31 M(-0.3%) |
| Dec 2009 | $12.55 M(-35.2%) | $31.41 M |
| Dec 2008 | $19.36 M | - |
FAQ
- What is Pacira BioSciences annual long term assets?
- What is the all time high annual non current assets for Pacira BioSciences?
- What is Pacira BioSciences annual non current assets year-on-year change?
- What is Pacira BioSciences quarterly long term assets?
- What is the all time high quarterly non current assets for Pacira BioSciences?
- What is Pacira BioSciences quarterly non current assets year-on-year change?
What is Pacira BioSciences annual long term assets?
The current annual non current assets of PCRX is $1.06 B
What is the all time high annual non current assets for Pacira BioSciences?
Pacira BioSciences all-time high annual long term assets is $1.21 B
What is Pacira BioSciences annual non current assets year-on-year change?
Over the past year, PCRX annual long term assets has changed by -$118.47 M (-10.02%)
What is Pacira BioSciences quarterly long term assets?
The current quarterly non current assets of PCRX is $831.72 M
What is the all time high quarterly non current assets for Pacira BioSciences?
Pacira BioSciences all-time high quarterly long term assets is $1.22 B
What is Pacira BioSciences quarterly non current assets year-on-year change?
Over the past year, PCRX quarterly long term assets has changed by -$255.49 M (-23.50%)